EverSweet® + ClearFlo™ (EC1)

EverSweet+ClearFlo (EC1), a game-changing product, combines EverSweet,
Reb M-based stevia sweetener (best-tasting part of stevia plant) with
ClearFlo natural flavor, marking first-ever solution of its kind. EC1
improves flavors, mouthfeel, dissolution and solubility. Allows for
expanded stevia uses. ECI reduces sugar across myriad food/beverages.

Blue Urea

Urea is one of the widely used nitrogen fertilizers in agriculture. Urea
production is linked to production of its precursor ammonia, which is
linked to considerable CO2 emissions. Our innovation is mainly focused
about offering Blue or Low carbon Urea that is produced utilizing third
party certified (TÜV-R) Blue Ammonia with zero Carbon Footprint.

PhycoTerra® ST

PhycoTerra® ST, our award-winning microalgal seed treatment, feeds the
beneficial microbes in the spermosphere – your seed’s first interaction
with the soil. By coating the seed with a high-quality carbon source,
PhycoTerra® ST improves soil quality and structure, supporting crop
germination, establishment, and vigor – leading to optimized yield.

Next Generation Fertilizer

“unique Multinutrient foliar fertilizer developed with crop yield
building & protecting components in a single formulation, to provide
a wholesome nutrition & stress protection to plants. Studies on
developed formulation showed 17.8% improvement in yield & 12-40%
improvements in growth parameters on Marigold crop, with 25% reduced
fertilizer use”

BioDrone® platform

BioDrone™ is a next-generation drug delivery platform that relies on
cell-derived vesicles obtained from MDimune’s proprietary extrusion
technology that converts virtually any human cells into nanovesicles.
BioDrone™ is safe and highly effective in the targeted delivery of
various drugs, thereby reducing side effects and maximizing efficacy.

Vivistim® Paired VNS™ System

The FDA-approved Vivistim® Paired VNS™ System is a first-of-its-kind
breakthrough technology that uses vagus nerve stimulation in conjunction
with in-clinic rehabilitation therapy to help generate 2-3 times more
hand and arm function for ischemic stroke survivors than rehabilitation
therapy alone.

Nose It All™️

Nose It All™️is a medical-grade oral device that stops nosebleeds at the
arterial source, up to 3x faster than any traditional method. Inserted
under the top lip, pressure is directed upwards toward the anterior
artery using the patented bite tab, stopping nosebleeds in as little as
3 minutes, hands-free, without tissues, sponges, or chemicals.

eXciteOSA®

eXciteOSA is the first FDA-authorized, non-invasive daytime therapy that
targets a root cause of OSA and snoring by improving the endurance of
the tongue muscle. It’s clinically proven to reduce OSA and snoring in 6
weeks. The therapy combines a digital platform to foster patient
adherence, a device, and the expertise of a Sleep Advocate team.

Viz Aneurysm Software

Viz Aneurysm, the first fully-automated AI algorithm to receive
FDA-clearance, detects suspected cerebral aneurysms, which can
potentially rupture if not actively monitored. Mobile, HIPAA-compliant
communication tools ensure that the aneurysm workflow across the entire
health system is standardized, so more patients get neurovascular
follow-up.

STIMVIEW™ XT

Deep Brain Stimulation (DBS) is designed to bring symptom relief to
those suffering from movement disorders (e.g. Parkinson’s) by delivering
targeted electrical stimulation to an area in the brain the size of an
apple seed. Image software STIMVIEW XT uses a 3D patient-specific
anatomy to enable clinicians to see, shape, and steer DBS therapy.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report